You are here

anemia

U.S. paves way for Novartis to copy Amgen biotech drug

Yahoo/Reuters

Thu, 07/24/14 - 09:07 am

Some cancer docs still bill heavily for Amgen's Epogen despite safety questions

Fierce Pharma

Mon, 06/23/14 - 12:53 pm

Affymax and Takeda Announce Termination of Omontys (peginesatide) Product Collaboration and License Agreement

Pipeline Review

Sat, 06/14/14 - 09:51 am

Celgene anemias treatment granted FDA orphan designation

Yahoo/Fly on the Wall

Tue, 04/29/14 - 09:43 am

IPO Could Be Too Little, Too Early For Akebia Therapeutics

Seeking Alpha

Tue, 03/18/14 - 01:37 pm

Akebia Therapeutics

Acceleron, Celgene Vs. Amgen In The Anemia Drug Race

Seeking Alpha

Mon, 12/30/13 - 11:15 am

Astellas, GSK vie to make 'high altitude' anemia pill

Reuters

Fri, 04/19/13 - 08:52 am

Cipla steamrolls into Enbrel market with biosimilar of Amgen drug

Fierce Pharma

Thu, 04/18/13 - 08:34 am

FDA saw early reports of severe Omontys reactions: WSJ

Fierce Pharma

Mon, 04/1/13 - 11:20 am

Yet Another Negative Trial For Amgen's Aranesp

Forbes

Mon, 03/11/13 - 11:03 am

Down 85%! Why Affymax Is Getting Crushed This Morning

Motley Fool

Mon, 02/25/13 - 09:50 am

Amgen’s Aranesp for Anemia Fails to Help Heart Patients

Bloomberg

Thu, 01/17/13 - 08:47 am

Amgen Pleads Guilty to Misbranding Anemia Drug Aranesp

Bloomberg

Tue, 12/18/12 - 11:17 am

Amgen's Epogen: Can This Blockbuster Drug Keep Shining?

Motley Fool

Mon, 10/29/12 - 11:40 am

How A $440,000 Drug Is Turning Alexion Into Biotech's New Innovation Powerhouse

Forbes

Wed, 09/5/12 - 12:51 pm

Amag to pitch anemia drug for wider indication

Reuters

Wed, 07/18/12 - 12:38 pm

Amag Pharmaceuticals

Affymax Rises On Deal With Fresenius For Kidney Therapy

Bloomberg

Fri, 07/13/12 - 12:25 pm

DaVita agrees to pay $55 million to settle suit over Epogen overuse

Yahoo/AP

Thu, 07/5/12 - 01:20 pm

AMAG To Get $15 Million Milestone Payment From Takeda as Iron Therapy Drug Approved for Europe

WSJ

Sat, 06/23/12 - 01:14 pm

Amag Pharmaceuticals

Pages